Skip to main content
NIHPA Author Manuscripts logoLink to NIHPA Author Manuscripts
. Author manuscript; available in PMC: 2021 Feb 7.
Published in final edited form as: Org Lett. 2020 Jan 15;22(3):1046–1051. doi: 10.1021/acs.orglett.9b04568

Multifunctional Building Blocks Compatible with Photoredox-Mediated Alkylation for DNA-Encoded Library Synthesis

Shorouk O Badir †,§, Jaehoon Sim †,§, Katelyn Billings , Adam Csakai , Xuange Zhang , Weizhe Dong , Gary A Molander †,*
PMCID: PMC7060506  NIHMSID: NIHMS1068030  PMID: 31940210

Abstract

DNA-Encoded Library (DEL) technology has emerged as a novel interrogation modality for ligand discovery in the pharmaceutical industry. Given the increasing demand for a higher proportion of C(sp3)-hybridized centers in DEL platforms, a photoredox-mediated cross-coupling and defluorinative alkylation process is introduced using commercially available alkyl bromides and structurally diverse α-silylamines. Notably, no protecting group strategies for amines are necessary for the incorporation of a variety of amino acid-based organosilanes, providing crucial branching points for further derivatization.

Graphical Abstract

graphic file with name nihms-1068030-f0001.jpg

INTRODUCTION

The discovery of small organic ligands with high-affinity binding to proteins is a central theme of biomedical research in both academic and industrial settings.1 Robust chemical probes are key to validating the tractability and translatability of a therapeutic target in drug discovery programs, and they provide a critical starting point for the development of new therapeutic chemical entities.2 Consequently, considerable attention has been devoted to the development of novel screening methods that diminish clinical attrition and to identify chemical matter with superior specificity more rapidly.

In the search for novel therapeutic compound classes, a strategy has evolved to cast a wide net to capture as many potential hit compounds as possible across a broad range of substructures. Owing to the need for individual synthesis and screening of small molecules that make up a conventional HTS library, campaigns of a few million compounds against a complex biological target have proven to be cost and time intensive, with an estimated price tag of $1,000 per library member.1,3 In recent years, DNA-encoded library (DEL) technology4 has emerged as an innovative platform to enable the assembly and sampling of combinatorial libraries of unprecedented magnitude (>106 to 1012 drug-like candidates).5 Originally conceived by Brenner and Lerner in 1992, DELs are composed of small molecules covalently conjugated with a DNA tag, which functions as a molecular identifier or barcode for each subunit.6 By harnessing split-and-pool routines, an entire library can be made in a few months by 1–2 chemists and, in a single experiment, screened against immobilized biomolecular targets (Figure 1).7 Once non-binders are washed away, the desired ligands are released under denaturing conditions, and subsequently the chemical structures are decoded via PCR amplification and DNA sequencing.8 In this vein, DEL screens provide a time- and cost-effective format for exploration of uncharted chemical space.

Figure 1.

Figure 1.

Schematic presentation of DNA-encoded library technology

A wide array of medicinal candidates has been identified from DEL platforms.9 The inherent nature of the DNA barcode, however, renders the implementation of such synthetic transformations challenging. On-DNA reactions must be compatible with water, must be performed at high dilutions, must be high-yielding with the ability to identify any major byproducts, should be user-friendly, and must avoid the use of strong bases and harsh oxidizing or reducing agents.10 Recent work by the Baran and Dawson groups11 to increase the solubility of DNA tags in organic solvents utilizing cationic resins has been demonstrated, but this protocol presents its own obstacles when merged with photoredox-mediated alkylation processes. Therefore, myriad structural gaps persist in DEL paradigms, with an increasing need to incorporate functional groups amenable to sequential derivatization.

To ensure a versatile chemical foundation, careful selection of building blocks (BBs) is instrumental in constructing libraries. A comprehensive set of BBs encompassing structural motifs that resemble bioactive molecules in combination with those bearing an additional handle for diversification is ideal.12 Although mono-functional BBs suitable for existing DEL chemistries are widely accessible, a recent survey estimates that the number of available bifunctional BBs, serving as crucial linkers, encompasses only ~3,500 scaffolds.12 In light of these considerations, we sought to expand the BBs amenable for photoredox-catalyzed DEL synthesis to incorporate two complementary families of radical precursors, namely aliphatic bromides13 and α-silylamines.14

In recent years, metallaphotoredox catalysis has emerged as a valuable tool for providing unique and alternative C—C bond disconnections, especially in the context of complex biomolecular design.15 Because of the impact of C(sp3)-hybridized centers on the enhancement of solubility and specificity in druggable molecules, single electron transfer (SET) processes have found extensive use in the medicinal chemistry community.16,17

Recently, our group and others have validated Ni/photoredox dual catalysis in DNA-encoded synthesis using carboxylic acids and 1,4-dihydropyridines (DHPs) as radical precursors.18,19 Although this advancement presented a milestone in its own right, the scope of these transformations was restricted to α-amino acids, which generate stabilized α-heterosubstituted radicals.18,19 In the case of DHPs, the cross-coupling was limited to benzylic, secondary, or α-alkoxy structural motifs.18

To address these limitations, we sought to develop three photoredox approaches to expand chemical space in the DEL platform. In the first, a photoredox/nickel-mediated reductive coupling on DNA was developed, employing primary and secondary alkyl bromides as reaction partners using triethylamine as a mild reductant. Such cross-electrophile couplings furnish several advantages over traditional catalytic cycles.20 For example, the need for preformed carbon nucleophiles, including harsh organometallic reagents prepared from the corresponding halides, severely limits functional group compatibility and renders such anionic alkylation processes unusable in DEL environments.21 By contrast, electrophilic reagents such as aliphatic halides have greater abundance and offer excellent structural complexity, with over 2 million building blocks commercially available. Bypassing the need for stoichiometric zinc or manganese reductants, we disclose a versatile cross-coupling with excellent functional group tolerance on DNA.

In two further protocols, α-silylamines have been incorporated as surrogates of structural motifs embedded within natural products.12,22 We have thus engaged several members of this class of substrates in both Ni/photoredox dual cross-coupling and defluorinative alkylation processes. Importantly, all of the protocols developed are completed within minutes and do not require an inert atmosphere, providing an exceedingly low barrier to practical implementation.

A fundamental challenge facing cross-electrophile couplings is selectivity.20 Because of the labile nature of both electrophilic starting materials toward oxidative addition in the presence of a nickel catalyst, careful design of reaction parameters must be implemented to synchronize the nickel and photoredox catalytic cycles (Figure 2A).13

Figure 2.

Figure 2.

Plausible catalytic cycle, key optimization parameters, and scope of this transformation.

To induce selectivity in substrates with inherently equal or similar reactivities, excess amounts of one reagent over the other can be leveraged.20,23 This strategy is particularly powerful in the context of DEL chemistries, which are carried out on extremely small scale (~25 nmol).18 To clarify this perspective further, the use of 250 equivalents of radical precursor only equates to 6.25 μmol of starting material. Notably, the ease of separation of homodimers from DNA-alkylated products further highlights the potential of implementing cross-electrophile couplings in DEL strategies.

We initiated our studies using a DNA-tagged para-substituted aryl bromide (1) and 4-bromotetrahydropyran as the model substrates under 20% aqueous conditions (Figure 2). Given the reductive nature of this transformation, a variety of photocatalysts were screened (Figure 2B). Although product formation was observed in the case of the organic dye 1,2,3,5-tetrakis(carbazol-9-yl)-4,6-dicyanobenzene (4CzIPN),24 the iridium-based photoreductant [Ir(dtbbpy)(ppy)2]PF6 (E1/2 = −0.96 V vs SCE) proved superior.25,26 Of particular note, minimal product was generated using 10-phenylphenothiazine (PTH). With a drastically higher reduction potential (E1/2 = −2.1 V vs. SCE) compared to Ir(ppy)3 (E1/2 = −1.7 V vs. SCE),27 this photoreductant presumably engages the aryl halide on DNA in protodehalogenation via reductive fragmentation of the corresponding C—X bond. After assessing a variety of parameters, a loading of 250 equiv of alkyl bromide, coupled with a 4:1 ratio of the NiBr2•bpy precomplex-to-photocatalyst, was determined to afford the desired product in suitable yield. The addition of magnesium chloride (MgCl2) was utilized to enhance stabilization of the DNA backbone.28 Of note, the reactions were complete in <45 min and did not require an inert atmosphere.

We subsequently evaluated the scope of this reductive coupling (Figure 2C). A wide range of primary and secondary alkyl bromides served as competent substrates, including those with bifunctional handles such as N-Boc-protected amine 3d, unactivated alkene 3i, alkyl chlorides 3j and 3k, and nitrile 3o. Because of the mild base utilized, free alcohols 3l-n, stemming from a primary alkyl bromide, were effectively coupled in acceptable yields. The scope of this method was further extended to cyclic systems, including oxetane 3c, azetidine 3d, and pyran 3g.

To establish robust reactivity, we surveyed these DNA substrates with one primary and one secondary alkyl bromide (Figure 2D). Aryl bromides and iodides bearing electron-withdrawing and electron-donating groups were cross-coupled effectively. Activated heteroaryl systems (3ab, 3ac, 3ad) reacted in moderate yields because of their delicate nature under reducing photoredox conditions. This limitation, however, complements existing SET-mediated cross-coupling procedures operating under an oxidative fragmentation paradigm.18,19 By contrast, electron-neutral aryl bromides, not viable under previous reports,38,39 furnished the desired alkylated products in moderate yields in this cross-electrophile coupling. A variety of other structural motifs were accommodated, including aryl fluoride 3ae, styrene 3af, N-Boc-protected amines (3oj and 3ok), aldehyde 3al, and free primary amines (3om and 3on). Remarkably, aryl halide 3ao, containing a morpholine residue, did not suffer diminished reactivity, despite its structural resemblance to the triethylamine used as a stoichiometric reducing agent in this reaction.

Having explored the utility of alkyl bromides as electrophilic cross-coupling partners on DNA, we then investigated α-silylamines as radical precursors.14 An ambitious goal of unbiased DNA-encoded libraries aimed at multiple biological targets is to encompass a large collection of diverse scaffolds.28 Inspired by the concept of diversity-oriented synthesis (DOS), first championed by Schreiber in 2000,29 we pursued the aminomethylation of (hetero)aryl bromides to yield skeletal diversity prevalent in natural products (Figure 3). Indeed, the aminomethyl subunit serves as a pivotal linker in bioactive molecules as well as leading pharmaceutical drugs such as Imatinib and Donepezil.14,30 Strategies based on DOS attest to their success in the discovery of new therapeutic treatments,31 especially in DNA-encoded library synthesis as described recently by Schreiber et al.32

Figure 3.

Figure 3.

Cross-coupling and radical/polar defluorinative aminomethylation.

We envisioned that single-electron oxidation of electron-rich alkyl(trimethyl)silanes 4 under photoredox conditions would give rise to silyl radical cations.14,33 This species would undergo facile desilylation to yield the desired α-aminomethyl radical, which could then be intercepted by the nickel catalytic cycle to furnish the coupled product. We anticipated that nucleophilically assisted desilylation could occur when using water as a (co)solvent. This added benefit could be further leveraged as the free amine handle allows systematic branching sequences in DEL platforms. Driven by low oxidation potentials in protic solvents,33 we demonstrate for the first time that unprotected aminomethylsilanes are efficiently oxidized by [Ir{dFCF3ppy}(bpy)]PF6. Notably, diverse alkyl(trimethyl)silanes can be accessed in a single step from the corresponding commercially available amines and chlorotrimethylsilane. Importantly, the reactions require less than 15 min to proceed to completion and are carried out in the absence of an inert atmosphere.

The bifunctional nature and commercial availability of amino acids make them highly valued building blocks for library synthesis, and we successfully carried out the aminomethylation with a variety of electron-deficient and electron-rich halides with an organosilane stemming from proline to produce synthetically useful levels of product. Aryl iodides bearing N-Boc protected amine 5p served as a competent substrate. Additionally, aryl iodides bearing a free amine 5n and tertiary amine 5o both reacted with ease. We have successfully demonstrated the cross-coupling with non-amino acid-derived organosilanes (5b and 5c).

Given the metabolic stability of gem-difluoroalkenes as carbonyl mimics,34 we subjected α-silylamines to radical/polar crossover defluorinative alkylation processes (Figure 3D).18,35 We propose that a single-electron oxidation of the α-silylamine radical precursor by the photoexcited state of the photocatalyst furnishes a nucleophilic primary radical. This species then undergoes addition to the trifluoromethyl alkene to generate an α-CF3 radical, which is further reduced to the carbanion by the photocatalyst. Subsequent fluoride elimination occurs to yield 7.18,35

After extensive reaction optimization, we assessed the scope of this transformation (Figure 3E). A wide array of amino acid-based organosilanes proved competent, including leucine 7e, phenylalanine 7f, proline 7h, methionine 7i, and tryptophan 7k. Remarkably, nitrogen protecting groups were not necessary in this alkylation platform, providing an additional branching point to be utilized for further building block incorporation.

Numerous other silylamines, derived from commercially available aminomethylsilane and the corresponding ketones/aldehydes via reductive amination, displayed adequate reactivity with a variety of substrates, including aniline 7a, glycoside 7l, oxetane 7m, pyridine 7o, and amide 7p. Notably, we subjected aminomethyltrimethylsilane to the reaction conditions and obtained the primary amine 7q without any loss in reactivity. We foresee that the structural diversity created in these photoredox-mediated processes will be instrumental in providing unique and alternative bond disconnections in DEL libraries.

Finally, maintaining the integrity of the DNA tag during library synthesis is vital to the success of encoded library technology (ELT) as a drug discovery platform because the DNA barcode is the only record available to decode the synthetic steps used to construct the putative binder following selection. We verified the integrity of the DNA tag when subjected to the photoredox conditions developed herein (see Supporting Information for details). We observed no significant differences in the ability of our samples treated with standard conditions to undergo ligation, PCR amplification, quantification, or sequencing when compared to a no-blue light exposed control sample. These results, consistent with historical findings,18 suggest that the reported transformations are amenable for DEL synthesis without compromising the integrity of the DNA.

In summary, taking advantage of diverse and commercially available alkyl bromides, a selective cross-electrophile coupling on DNA has been devised. A variety of unactivated primary and secondary radical precursors are employed with high functional group tolerance. Of further advantage, photoredox-mediated radical/polar crossover reactions using structurally diverse α-silylamines were employed to generate novel gem-difluoroalkene scaffolds without the need for nitrogen protecting groups.

Supplementary Material

SI

ACKNOWLEDGMENT

The authors are grateful for the financial support provided by NIGMS (R35 GM 131680 to G.M.) We thank Dr. Charles W. Ross, III (UPenn) for his assistance in obtaining LCMS and HRMS data. We thank Dr. Svetlana Belyanskaya (GSK) and Divya Parikh (GSK) for their assistance obtaining qPCR and sequencing data. We thank Johnson Matthey for the donation of iridium(III) chloride and Kessil for donation of lamps.

Footnotes

Supporting Information

Detailed experimental procedures (including workflow and qPCR/sequencing of representative examples), preparation of on-DNA substrates and α-silylmethylamines, characterization data, NMR spectra for new compounds, and UPLC/MS of on-DNA reactions.

The Supporting Information is available free of charge on the ACS Publications website.

The authors declare no competing financial interest.

REFERENCES

  • (1).Neri D; Lerner RA DNA-Encoded Chemical Libraries: A Selection System Based on Endowing Organic Compounds with Amplifiable Information. Annu. Rev. Biochem 2018, 87, 479–502. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • (2).Garbaccio RM; Parmee ER The Impact of Chemical Probes in Drug Discovery: A Pharmaceutical Industry Perspective. Cell Chem. Biol 2016, 23, 10–17. [DOI] [PubMed] [Google Scholar]
  • (3).For selected examples, see:; a) Erlanson DA; Fesik SW; Hubbard RE; Jahnke W; Jhoti H Twenty years on: the impact of fragments on drug discovery. Nat. Rev. Drug. Discov 2016, 15, 605–619. [DOI] [PubMed] [Google Scholar]; (b) Folmer RHA Integrating biophysics with HTS-driven drug discovery projects. Drug Discov. Today Technol 2016, 21, 491–498. [DOI] [PubMed] [Google Scholar]; (c) Halai R; Cooper MA Using label-free screening technology to improve efficiency in drug discovery. Expert Opin Drug Dis. 2012, 7, 123–131. [DOI] [PubMed] [Google Scholar]; (d) Nielsen TE; Schreiber SL Diversity-oriented synthesis - Towards the optimal screening collection: A synthesis strategy. Angew. Chem., Int. Ed 2008, 47, 48–56. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • (4).Dickson P; Kodadek T Chemical composition of DNA-encoded libraries, past present and future. Org. Biomol. Chem 2019, 17, 4676–4688. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • (5).For selected examples, see:; (a) Clark MA; Acharya RA; Arico-Muendel CC; Belyanskaya SL; Benjamin DR; Carlson NR; Centrella PA; Chiu CH; Creaser SP; Cuozzo JW; Davie CP; Ding Y; Franklin GJ; Franzen KD; Gefter ML; Hale SP; Hansen NJV; Israel DI; Jiang JW; Kavarana MJ; Kelley MS; Kollmann CS; Li F; Lind K; Mataruse S; Medeiros PF; Messer JA; Myers P; O’Keefe H; Oliff MC; Rise CE; Satz AL; Skinner SR; Svendsen JL; Tang LJ; van Vloten K; Wagner RW; Yao G; Zhao BG; Morgan BA Design, synthesis and selection of DNA-encoded small-molecule libraries. Nat. Chem. Biol 2009, 5, 647–654. [DOI] [PubMed] [Google Scholar]; (b) Litovchick A; Dumelin CE; Habeshian S; Gikunju D; Guie MA; Centrella P; Zhang Y; Sigel EA; Cuozzo JW; Keefe AD; Clark MA Encoded Library Synthesis Using Chemical Ligation and the Discovery of sEH Inhibitors from a 334-Million Member Library. Sci. Rep 2015, 5, 10916. [DOI] [PMC free article] [PubMed] [Google Scholar]; (c) Harris PA; King BW; Bandyopadhyay D; Berger SB; Campobasso N; Capriotti CA; Cox JA; Dare L; Dong XY; Finger JN; Grady LC; Hoffmann SJ; Jeong JU; Kang J; Kasparcova V; Lakdawala AS; Lehr R; McNulty DE; Nagilla R; Ouellette MT; Pao CS; Rendina AR; Schaeffer MC; Summerfield JD; Swift BA; Totoritis RD; Ward P; Zhang AM; Zhang DH; Marquis RW; Bertin J; Gough PJ DNA-Encoded Library Screening Identifies Benzo[b][1,4]oxazepin-4-ones as Highly Potent and Monoselective Receptor Interacting Protein 1 Kinase Inhibitors. J. Med. Chem 2016, 59, 2163–2178. [DOI] [PubMed] [Google Scholar]; (d) Mullard A, DNA Tags Help the Hunt for Drugs. Nature 2016, 530, 367–369. [DOI] [PubMed] [Google Scholar]
  • (6).Brenner S; Lerner RA Encoded combinatorial chemistry. Proc. Natl. Acad. Sci. U. S. A 1992, 89, 5381–5383. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • (7).Ottl J; Leder L; Schaefer JV; Dumelin CE Encoded Library Technologies as Integrated Lead Finding Platforms for Drug Discovery. Molecules 2019, 24, 1629. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • (8).For selected examples, see:; (a) Buller F; Mannocci L; Scheuermann J; Nerit D Drug Discovery with DNA-Encoded Chemical Libraries. Bioconjugate Chem. 2010, 21, 1571–1580. [DOI] [PubMed] [Google Scholar]; (b) Kleiner RE; Dumelin CE; Liu DR Small-molecule discovery from DNA-encoded chemical libraries. Chem. Soc. Rev 2011, 40, 5707–5717. [DOI] [PMC free article] [PubMed] [Google Scholar]; (c) Ding Y; Franklin GJ; DeLorey JL; Centrella PA; Mataruse S; Clark MA; Skinner SR; Belyanskaya S Design and Synthesis of Biaryl DNA-Encoded Libraries. ACS Comb. Sci 2016, 18, 625–629. [DOI] [PubMed] [Google Scholar]
  • (9).For selected examples, see:; (a) Maianti JP; McFedries A; Foda ZH; Kleiner RE; Du XQ; Leissring MA; Tang WJ; Charron MJ; Seeliger MA; Saghatelian A; Liu DR Anti-diabetic activity of insulin-degrading enzyme inhibitors mediated by multiple hormones. Nature 2014, 511, 94–98. [DOI] [PMC free article] [PubMed] [Google Scholar]; (b) Ding Y; O’Keefe H; DeLorey JL; Israebt DI; Messer JA; Chiu CH; Skinner SR; Matico RE; Murray-Thompson MF; Li F; Clark MA; Cuozzo JW; Arico-Muendel C; Morgan BA Discovery of Potent and Selective Inhibitors for ADAMTS-4 through DNA-Encoded Library Technology (ELT). ACS Med. Chem. Lett 2015, 6, 888–893. [DOI] [PMC free article] [PubMed] [Google Scholar]; (c) Samain F; Ekblad T; Mikutis G; Zhong N; Zimmermann M; Nauer A; Bajic D; Decurtins W; Scheuermann J; Brown PJ; Hall J; Graslund S; Schuler H; Neri D; Franzinit RM Tankyrase 1 Inhibitors with Drug-like Properties Identified by Screening a DNA-Encoded Chemical Library. J. Med. Chem 2015, 58, 5143–5149. [DOI] [PubMed] [Google Scholar]; (d) Li YZ; De Luca R; Cazzamalli S; Pretto F; Bajic D; Scheuermann J; Neri D Versatile protein recognition by the encoded display of multiple chemical elements on a constant macrocyclic scaffold. Nat. Chem 2018, 10, 441–448. [DOI] [PMC free article] [PubMed] [Google Scholar]; (e) Cuozzo JW; Centrella PA; Gikunju D; Habeshian S; Hupp CD; Keefe AD; Sigel EA; Soutter HH; Thomson HA; Zhang Y; Clark MA Discovery of a Potent BTK Inhibitor with a Novel Binding Mode by Using Parallel Selections with a DNA-Encoded Chemical Library (vol 18). Chembiochem. 2017, 18, 2441–2441. [DOI] [PubMed] [Google Scholar]; (f) Brown DG; Brown GA; Centrella P; Certel K; Cooke RM; Cuozzo JW; Dekker N; Dumelin CE; Ferguson A; Fiez-Vandal C; Geschwindner S; Guie MA; Habeshian S; Keefe AD; Schlenker O; Sigel EA; Snijder A; Soutter HT; Sundstrom L; Troast DM; Wiggin G; Zhang J; Zhang Y; Clark MA Agonists and Antagonists of Protease-Activated Receptor 2 Discovered within a DNA-Encoded Chemical Library Using Mutational Stabilization of the Target. SLAS Discov. 2018, 23, 429–436. [DOI] [PubMed] [Google Scholar]; (g) Petersen LK; Blakskjaer P; Chaikuad A; Christensen AB; Dietvorst J; Holmkvist J; Knapp S; Korinek M; Larsen LK; Pedersen AE; Rohm S; Slok FA; Hansen NJV Novel p38 alpha MAP kinase inhibitors identified from yoctoReactor DNA-encoded small molecule library. Medchemcomm. 2016, 7, 1332–1339. [Google Scholar]; (h) Ahn S; Kahsai AW; Pani B; Wang QT; Zhao S; Wall AL; Strachan RT; Staus DP; Wingler LM; Sun LD; Sinnaeve J; Choi MJ; Cho T; Xu TT; Hansen GM; Burnett MB; Lamerdin JE; Bassoni DL; Gavino BJ; Husemoen G; Olsen EK; Franch T; Costanzi S; Chen X; Lefkowitz RJ Allosteric “beta-blocker” isolated from a DNA-encoded small molecule library. PNAS USA 2017, 114, 1708–1713. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • (10).(a) Malone ML; Paegel BM What is a “DNA-Compatible” Reaction?. ACS Comb. Sci 2016, 18, 182–187. [DOI] [PMC free article] [PubMed] [Google Scholar]; (b) Satz AL; Cai JP; Chen Y; Goodnow R; Gruber F; Kowalczyk A; Petersen A; Naderi-Oboodi G; Orzechowski L; Strebel Q DNA Compatible Multistep Synthesis and Applications to DNA Encoded Libraries. Bioconjugate Chem. 2015, 26, 1623–1632. [DOI] [PubMed] [Google Scholar]
  • (11).Flood DT; Asai S; Zhang XJ; Wang J; Yoon L; Adams ZC; Dillingham BC; Sanchez BB; Vantourout JC; Flanagan ME; Piotrowsld DW; Richardson P; Green SA; Shenvi RA; Chen JS; Baran PS; Dawson PE Expanding Reactivity in DNA-Encoded Library Synthesis via Reversible Binding of DNA to an Inert Quaternary Ammonium Support. J. Am. Chem. Soc 2019, 141, 9998–10006. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • (12).Zhao GX; Huang YR; Zhou Y; Li YZ; Li XY Future challenges with DNA-encoded chemical libraries in the drug discovery domain. Expert Opin Drug Dis. 2019, 14, 735–753. [DOI] [PubMed] [Google Scholar]
  • (13).Duan ZL; Li W; Lei AW Nickel-Catalyzed Reductive Cross-Coupling of Aryl Bromides with Alkyl Bromides: Et3N as the Terminal Reductant. Org. Lett 2016, 18, 4012–4015. [DOI] [PubMed] [Google Scholar]
  • (14).Remeur C; Kelly CB; Patel NR; Molander GA Aminomethylation of Aryl Halides Using alpha-Silylamines Enabled by Ni/Photoredox Dual Catalysis. ACS Catal. 2017, 7, 6065–6069. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • (15).(a) Tellis JC; Primer DN; Molander GA Single-electron transmetalation in organoboron cross-coupling by photoredox/nickel dual catalysis. Science 2014, 345, 433–436. [DOI] [PMC free article] [PubMed] [Google Scholar]; (b) Milligan JA; Phelan JP; Badir SO; Molander GA, Alkyl Carbon-Carbon Bond Formation by Nickel/Photoredox Cross-Coupling. Angew. Chem., Int. Ed 2019, 58, 6152–6163. [DOI] [PMC free article] [PubMed] [Google Scholar]; (c) Twilton J; Le C; Zhang P; Shaw MH; Evans RW; MacMillan DWC The merger of transition metal and photocatalysis. Nat. Rev. Chem 2017, 1, 0052. [Google Scholar]
  • (16).Brown DG; Bostrom J Analysis of Past and Present Synthetic Methodologies on Medicinal Chemistry: Where Have All the New Reactions Gone? J. Med. Chem 2016, 59, 4443–4458. [DOI] [PubMed] [Google Scholar]
  • (17).Schneider N; Lowe DM; Sayle RA; Tarselli MA; Landrum GA Big Data from Pharmaceutical Patents: A Computational Analysis of Medicinal Chemists’ Bread and Butter. J. Med. Chem 2016, 59, 4385–4402. [DOI] [PubMed] [Google Scholar]
  • (18).Phelan JP; Lang SB; Sim J; Berritt S; Peat AJ; Billings K; Fan LJ; Molander GA, Open-Air Alkylation Reactions in Photoredox-Catalyzed DNA-Encoded Library Synthesis. J. Am. Chem. Soc 2019, 141, 3723–3732. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • (19).Kolmel DK; Meng J; Tsai MH; Que JM; Loach RP; Knauber T; Wan JQ; Flanagan ME, On-DNA Decarboxylative Arylation: Merging Photoredox with Nickel Catalysis in Water. Acs Comb Sci 2019, 21, 588–597. [DOI] [PubMed] [Google Scholar]
  • (20).Everson DA; Weix DJ Cross-Electrophile Coupling: Principles of Reactivity and Selectivity. J. Org. Chem 2014, 79, 4793–4798. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • (21).Mal D; Jana AK; Mitra P; Ghosh K Benzannulation for the Regiodefined Synthesis of 2-Alkyl/Aryl-1-naphthols: Total Synthesis of Arnottin I. J. Org. Chem 2011, 76, 3392–3398. [DOI] [PubMed] [Google Scholar]
  • (22).Gerry CJ; Wawer MJ; Clemons PA; Schreiber SL DNA Barcoding a Complete Matrix of Stereoisomeric Small Molecules. J. Am. Chem. Soc 2019, 141, 10225–10235. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • (23).Qian Q; Zang ZH; Wang SL; Chen Y; Lin KH; Gong HG Nickel-Catalyzed Reductive Cross-Coupling of Aryl Halides (vol 24, pg 619, 2013). Synlett. 2013, 24, 1164–1164. [Google Scholar]
  • (24).Cartier A; Levernier E; Corce V; Fukuyama T; Dhimane AL; Ollivier C; Ryu I; Fensterbank L Carbonylation of Alkyl Radicals Derived from Organosilicates through Visible-Light Photoredox Catalysis. Angew. Chem., Int. Ed 2019, 58, 1789–1793. [DOI] [PubMed] [Google Scholar]
  • (25).Duret G, Quinlan R, Bisseret P, and Blanchard N Boron chemistry in a new light. Chem. Sci 2015, 6, 5366–5382. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • (26).Klauck FJR; James MJ; Glorius F Deaminative Strategy for the Visible-Light-Mediated Generation of Alkyl Radicals. Angew. Chem., Int. Ed 2017, 56, 12336–12339. [DOI] [PubMed] [Google Scholar]
  • (27).Discekici EH; Treat NJ; Poelma SO; Mattson KM; Hudson ZM; Luo YD; Hawker CJ; de Alaniz JR A highly reducing metal-free photoredox catalyst: design and application in radical dehalogenations. Chem. Commun 2015, 51, 11705–11708. [DOI] [PubMed] [Google Scholar]
  • (28).Lu XJ; Fan LJ; Phelps CB; Davie CP; Donahue CP, Ruthenium Promoted On-DNA Ring-Closing Metathesis and Cross-Metathesis. Bioconjugate Chem 2017, 28, 1625–1629. [DOI] [PubMed] [Google Scholar]
  • (29).Schreiber SL Target-oriented and diversity-oriented organic synthesis in drug discovery. Science 2000, 287, 1964–1969. [DOI] [PubMed] [Google Scholar]
  • (30).Bolea I; Juarez-Jimenez J; de los Rios C; Chioua M; Pouplana R; Luque FJ; Unzeta M; Marco-Contelles J; Samadi A Synthesis, Biological Evaluation, and Molecular Modeling of Donepezil and N-[(5-(Benzyloxy)-1-methyl-1H-indol-2-yl)methyl]-N-methylprop-2-yn-1-amine Hybrids as New Multipotent Cholinesterase/Monoamine Oxidase Inhibitors for the Treatment of Alzheimer’s Disease. J. Med. Chem 2011, 54, 8251–8270. [DOI] [PubMed] [Google Scholar]
  • (31).Kato N; Comer E; Sakata-Kato T; Sharma A; Sharma M; Maetani M; Bastien J; Brancucci NM; Bittker JA; Corey V; Clarke D; Derbyshire ER; Dornan GL; Duffy S; Eckley S; Itoe MA; Koolen KMJ; Lewis TA; Lui PS; Lukens AK; Lund E; March S; Meibalan E; Meier BC; McPhail JA; Mitasev B; Moss EL; Sayes M; Van Gessel Y; Wawer MJ; Yoshinaga T; Zeeman AM; Avery VM; Bhatia SN; Burke JE; Catteruccia F; Clardy JC; Clemons PA; Dechering KJ; Duvall JR; Foley MA; Gusovsky F; Kocken CHM; Marti M; Morningstar ML; Munoz B; Neafsey DE; Sharma A; Winzeler EA; Wirth DF; Scherer CA; Schreiber SL Diversity-oriented synthesis yields novel multistage antimalarial inhibitors. Nature 2016, 538, 344–349. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • (32).Gerry CJ; Wawer MJ; Clemons PA; Schreiber SL DNA Barcoding a Complete Matrix of Stereoisomeric Small Molecules. J. Am. Chem. Soc 2019, 141, 10225–10235. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • (33).Cao ZY; Ghosh T; Melchiorre P, Enantioselective radical conjugate additions driven by a photoactive intramolecular iminium-ion-based EDA complex. Nat. Commun 2018, 9. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • (34).Magueur G; Crousse B; Ourevitch M; Bonnet-Delpon D; Begue JP Fluoro-artemisinins: When a gem-difluoroethylene replaces a carbonyl group. J. Fluorine Chem 2006, 127, 637–642. [Google Scholar]
  • (35).(a) Xiao TB; Li LY; Zhou L Synthesis of Functionalized gem-Difluoroalkenes via a Photocatalytic Decarboxylative/Defluorinative Reaction. J. Org. Chem 2016, 81, 7908–7916. [DOI] [PubMed] [Google Scholar]; (b) Lang SB; Wiles RJ; Kelly CB; Molander GA Photoredox Generation of Carbon-Centered Radicals Enables the Construction of 1,1-Difluoroalkene Carbonyl Mimics. Angew. Chem., Int. Ed 2017, 56, 15073–15077. [DOI] [PMC free article] [PubMed] [Google Scholar]

Associated Data

This section collects any data citations, data availability statements, or supplementary materials included in this article.

Supplementary Materials

SI

RESOURCES